Do specialists do it better? The impact of specialization on the processes and outcomes of care for cancer patients

Annals of Oncology

Volumn 9, Issue 4, 1998, Pages 365-374

  Grilli, R ^a   Minozzi, S ^a   Tinazzi, A ^a   Labianca, R ^b   Sheldon, T A ^c   Liberati, A ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b SAN CARLO BORROMEO HOSPITAL   (Italy)

^c UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Cancer care; Outcomes; Quality; Specialization; Systematic reviews

Indexed keywords

BREAST CARCINOMA; CANCER PATIENT; CLINICAL PRACTICE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; MEDICAL SPECIALIST; OUTCOMES RESEARCH; OVARY CARCINOMA; PRIORITY JOURNAL; REVIEW; SOLID TUMOR;

EID: 0031745781     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008201331167     Document Type: Review

References (61)

1. Sainsbury R, Rider L, Smith A et al. Does it matter where you live? Treatment variation for breast cancer in Yorkshire. Br J Cancer 1995; 71: 1275-8.
2. Haward RA. Establishing cancer units. Br J Cancer 1995; 72: 531-4.
3. Expert Advisory Group on Cancer. A Policy Framework for Commissioning Cancer Services. Department of Health. April 1995.
4. Sowden A, Deek JJ, Sheldon TA. Volume and outcome in coronary artery bypass graft surgery: True association or artefact? BMJ 1995; 311: 151-5.
5. Chu J, Polissar L, Tamini HK. Quality of care in women with stage I cervical cancer. West J Med 1982; 137: 13-7.
6. Duffner PK, Cohen ME, Flannery JT. Referral patterns of childhood brain tumors in the State of Connecticut. Cancer 1982; 50: 1636-40.
7. Meadows AT, Kramer S, Hopson R et al. Survival in childhood acute lymphocytic leukaemia: Effect of protocol and place of treatment. Cancer Invest 1983; 1: 49-55.
8. Kramer S, Meadows AT, Pastore G et al. Influence of place of treatment on diagnosis, treatment and survival in three paediatric solid tumours. J Clin Oncol 1984; 2: 917-23.
9. Liberati A, Mangioni C, Bratina L et al. Process and outcome of care for patients with ovarian cancer. BMJ 1985; 291: 1007-12.
10. G.I.V.I.O. (Interdisciplinary Group for Cancer Care Evaluation). Diagnosis and first-line treatment of breast cancer in Italian general hospitals. Tumori 1986; 72: 273-83.
11. Kelly JV, Hellinger FJ. Physician and hospital factors associated with mortality of surgical patients. Med Care 1986; 24: 785-800.
12. Davis S, Dahlberg S, Myers M et al. Hodgkin's disease in the United States: A comparison of patient characteristics and survival in the centralised cancer patient data system and the surveillance, epidemiology and end results program. J Natl Cancer Institute 1987; 78: 471-8.
13. Gill M, McCarthy M, Murrells T et al. Chemotherapy for the primary treatment of osteosarcoma: population effectiveness over 20 years. Lancet 1988; i: 689-92.
14. Sanders BM, Draper GJ, Kingston JE. Retinoblastoma in Great Britain 1969-1980: Incidence, treatment, and survival. Br J Ophthalmol 1988; 72: 576-83.
15. Stiller CA. Centralisation of treatment and survival rates for cancer. Arch Dis Child 1988; 63: 23-30.
16. Thornhill JA, Walsh A, Conroy RM et al. Physician-dependent prognostic variables in the management of teslicular cancer. Br J Urol 1988; 61: 244-9.
17. Hakama M, Karjalainen S, Hakulinen T. Outcome-based equity in the treatment of colon cancer patients in Finland. Inter J Tech Assess Health Care 1989; 5: 619-30.
18. Stiller CA, Draper GJ. Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia. Arch Dis Child 1989; 64: 657-61.
19. Karjalainen S. Geographical variation in cancer patient survival in Finland: Chance, confounding, or effect of treatment? J Epidemiol Commun Health 1990; 44: 210-4.
20. Bonett A, Roder D, Esterman A. Case-survival rates for infiltrating ductal carcinomas by category of hospital at diagnosis in South Australia. Med J Aust 1991; 154: 695-7.
21. Gillis CR, Hole DJ, Still RM et al. Medical audit, cancer registration, and survival in ovarian cancer. Lancet 1991; 337: 611-2.
22. Greenberg ER, Baron JA, Dain BJ et al. Cancer staging may have different meanings in academic and community hospitals. J Clin Epidcmiol 1991; 44: 505-12.
23. Gulliford MC, Petruckevitch A, Burney PGJ. Survival with bladder cancer, evaluation of delay in treatment, type of surgeon, and modality of treatment. BMJ 1991; 303: 437-40.
24. Hand R, Sener S, Imperato J et al. Hospital variables associated with quality of care for breast cancer patients. JAMA 1991; 266: 3429-32.
25. Basnett I, Gill M, Tobias JS. Variations in breast cancer management between a leaching and a non-teaching district. Eur J Cancer 1992; 28A: 1945-50.
26. Eisenkop SM, Spirtos NM, Montag TW et al. The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol Oncol 1992; 47: 203-9.
27. Mayer AR, Chambers SK, Graves E et al. Ovarian cancer staging: Does it require a gynecological oncologist? Gynecol Oncol 1992; 47: 223-7.
28. Nattinger AB, Gottlieb MS, Veum J et al. Geographic variation in the use of breast conserving treatment for breast cancer. N Engl J Med 1992; 326: 1102-7.
29. Ramsay A. Care of cancer patients in a home-based hospice program: A comparison of oncologists and primary care physicians. J Fam Practice 1992; 34: 170-4.
30. Romano PS, Mark DH. Patient and hospital characteristics related to in-hospital mortality after lung cancer resection. Chest 1992; 101: 1332-7.
31. Satariano ER, Swanson GM, Moll PP. Nonclinical factors associated with surgery received for treatment of early-stage breast cancer. Am J Publ Health 1992; 82: 195-8.
32. Grilli R, Mainini F, Penna A et al. Inappropriate Halsted mastectomy and patient volume in Italian hospitals. Am J Public Health 1993; 83: 1762-4.
33. Gulliford MC, Barton JR, Bourne HM. Selection for oesophagectomy and postoperative outcome in a defined population. Quality in Health Care 1993; 3: 17-20.
34. McGowan L. Patterns of care in carcinoma of the ovary. Cancer 1993; 71: 628-33.
35. Nguyen HN, Averette HE, Hoskins W et al. A National survey of ovarian carcinoma Part V. The impact of physician's specialty on patient's survival. Cancer 1993; 72: 3663-70.
36. Studnicki J, Shapira DV, Bradham DD et al. Response to the National Cancer Institute Alert. The effect of practice guidelines on two hospitals in the same medical community. Cancer 1993; 72: 2986-92.
37. Cleeland CS, Gonin R, Hatfield AK et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994; 330: 592-6.
38. Gustafson P, Dreinhofer KE, Rydholm A. Soft tissue sarcoma should be treated at a tumor center. A comparison of quality of surgery in 375 patients. Acta Orthop Scand 1994; 65: 47-50.
39. Hynes DM. The quality of breast cancer care in local communities: Implications for health care reforms. Med Care 1994; 32: 328-40.
40. Iscoe NA, Goel V, Wu K et al. Variation in breast cancer surgery in Ontario. Can Med Assoc J 1994; 150: 345-52.
41. Junor EJ, Hole DJ, Gillis CR. Management of ovarian cancer: Referral to a multidisciplinary team matters. Br J Cancer 1994; 70: 363-70.
42. Kehoe S, Powell J, Wilson S et al. The influence of the operating surgeon's specialization on patient survival in ovarian cancer. Br J Cancer 1994; 70: 1014-7.
43. Lee-Feldstein A, Anton-Culver H, Feldstein PJ. Treatment differences and other prognostic factors related to breast cancer survival. Delivery systems and medical outcomes. JAMA 1994; 271: 1163-8.
44. Samet JM, Hunt WC, Farrow DC. Determinants of receiving breast conserving surgery. The Surveillance. Epidemiology, and End Results Program, 1983-1986. Cancer 1994; 73: 2344-51.
45. Stiller CA, Eatock EM. Survival from acute non-lymphocytic leukaemia 1971 1988: A population-based study. Arch Dis Child 1994; 70: 657-61.
46. Foster RS, Farwell ME, Costanza ME. Breast-conserving surgery for breast cancer: Patterns of care in a geographic region and estimation of potential applicability. Ann Surg Oncol 1995; 2: 275-80.
47. Grilli R, Repetto F. Variation in use of breast conserving surgery in Lombardia, Italy. Inter J Tech Assess Health Care 1995; 11: 733-40.
48. Grunfeld E, Yudkin P, Adewuvi-Dalton R et al. Evaluating primary care follow-up of breast cancer: Methods and preliminary results of three studies. Ann Oncol 1995; 6 (Suppl 2): S47-S52.
49. Scorpiglione N, Nicolucci A, Grilli R et al. Appropriateness and variation of surgical treatment of breast cancer in Italy: When excellence in clinical research does not match with generalized quality of care. J Clin Epidemiol 1995; 48: 345-52.
50. Winstanley JHR, Leinster SJ, Wake PN et al. The value of guidelines in a breast screening service. Eur J Surg Oncol 1995; 21: 140-2.
51. Gillis CR, Hole DJ. Survival outcome of care by specialist surgeons in breast cancer: A study of 3786 patients in the west of Scotland. BMJ 1996; 312: 145-8.
52. Grunfeld E, Mant D, Yudkin Pet al. Routine follow up of breast cancer in primary care: Randomised trial. BMJ 1996; 313: 665-9.
53. Ebeling K, Tannenberg St, Nischan P et al. Bosatige Neubildungen der weiblichen Brustdruse in der Hauptstadt der DDR. Berlin, in der Periode 1975 bis 1979. Arch Geschwulstforsch 1982; 52: 307-21.
54. Von Slisow W, Marx G, Seifart W et al. Argumentation fur eine regionale zentralisierte Behandlung beim Magenkarzinom. Eine statistische Untersuchung von nationalen Resultaten. Zent b1 Chir 1987; 112: 27-33.
55. Mohner M, Slisow W. Untersuchung zum Einflub der regional zentralisierten Nehandlung auf die Uberlebenschancen beim Rektumkarzinom in der DDR. Zent b1 Chir 1990; 115: 801-12.
56. Sacks H, Chalmers T, Smith H. Randomized versus historical controls for clinical trials. Am J Med 1982; 72: 233-40.
57. Schulz KF, Chalmers I, Grimes DA et al. Assessing the quality of randomization from report of controlled trials publsihed in obstetrics and gynaecology journals. JAMA 1994; 272: 125-8.
58. Effective Health Care Bulletin. Implementing clinical practice guidelines: Can guidelines be used to improve clinical practice? University of York 1995.
59. Diabetes Integrated Care Evaluation Team. Integrated care for diabetes: Clinical, psychosocial, and economic evaluation BMJ 1994; 308: 1208-12.
60. Stiller C A: Centralised treatment, entry to trials and survival. Br J Cancer 1994; 70: 352-62.
61. Selby P, Gillis C, Haward R. Benefits from specialised cancer care. Lancet 1996; 348: 313-8.